A Phase II, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Latest Information Update: 25 Jan 2012
At a glance
- Drugs Tipelukast (Primary)
- Indications Interstitial cystitis
- Focus Therapeutic Use
- Sponsors MediciNova
- 25 Jan 2012 New trial record